Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  InMode Ltd.    INMD   IL0011595993

INMODE LTD.

(INMD)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
10/20/2020 10/21/2020 10/22/2020 10/23/2020 10/26/2020 Date
40.06(c) 42.01(c) 41.8(c) 41.49(c) 39.8(c) Last
688 810 654 009 712 713 470 059 597 247 Volume
+2.48% +4.87% -0.50% -0.74% -4.07% Change
More quotes
Financials (USD)
Sales 2020 183 M - -
Net income 2020 52,4 M - -
Net cash position 2020 301 M - -
P/E ratio 2020 33,1x
Yield 2020 -
Sales 2021 231 M - -
Net income 2021 78,0 M - -
Net cash position 2021 461 M - -
P/E ratio 2021 22,5x
Yield 2021 -
Capitalization 1 477 M 1 477 M -
EV / Sales 2020 6,44x
EV / Sales 2021 4,40x
Nbr of Employees 251
Free-Float 58,6%
More Financials
Company
Inmode Ltd is an Israel-based company. It designs, develops, manufactures and commercializes energy-based, minimally-invasive surgical aesthetic and medical treatment solutions. The Company‚Äôs proprietary technologies are used by physicians to remodel subdermal adipose, or fatty, tissue in a variety of procedures including fat reduction with simultaneous skin tightening, face and body contouring and ablative skin... 
More about the company
Notations Surperformance© of InMode Ltd.
Trading Rating : Investor Rating :
More Ratings
All news about INMODE LTD.
10/20INMODE : Introduces Morpheus8 Body Multi-pulse Burst Technology
PR
10/13INMODE : Expects Record Third Quarter Results, Revenues Between $59.2-$59.5M, No..
PR
08/05INMODE : 2Q Earnings Snapshot
AQ
08/05INMODE : Reports Second Quarter 2020 Financial Results; Quarterly Revenues of $3..
PR
08/03INMODE : to Present at Upcoming Virtual Conferences in August
PR
07/27INMODE : Technologies Win Major Beauty Awards
PR
07/13INMODE : to Report Second Quarter 2020 Financial Results on August 5, 2020; Mana..
PR
07/06INMODE : Announces NMPA (formerly CFDA) Approval for Two InMode Platforms in Chi..
PR
07/02Elizabeth Tallett Joins Moderna's Board of Directors
AQ
06/16INMODE : Receives Health Canada Certification for Evolve Tone
PR
05/11INMODE : to Participate at Upcoming Virtual Investor Conferences
PR
05/06INMODE : 1Q Earnings Snapshot
AQ
05/06INMODE : Reports First Quarter 2020 Financial Results; Quarterly Revenues of $40..
PR
04/07INMODE : to Report First Quarter 2020 Financial Results on May 6, 2020
PR
03/23INMODE : Provides COVID-19 Business Update
PR
More news
News in other languages on INMODE LTD.

- No features available -

More news
Chart INMODE LTD.
Duration : Period :
InMode Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends INMODE LTD.
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 3
Average target price 51,00 $
Last Close Price 41,49 $
Spread / Highest target 32,6%
Spread / Average Target 22,9%
Spread / Lowest Target 13,3%
EPS Revisions
Managers
NameTitle
Moshe Mizrahy Chairman & Chief Executive Officer
Yair Malca Chief Financial Officer
Michael Kreindel Chief Technology Officer & Director
Spero Theodorou Chief Medical Officer
Hadar Ron Director
Sector and Competitors
1st jan.Capitalization (M$)
INMODE LTD.5.84%1 477
THERMO FISHER SCIENTIFIC47.80%189 950
DANAHER CORPORATION51.59%165 276
INTUITIVE SURGICAL, INC.24.42%86 460
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.95.16%64 541
BOSTON SCIENTIFIC CORPORATION-17.80%53 178